This study extends our knowledge about the regulation of cyclin D1 and Ets1 at the post-transcriptional level by miRNA, and suggests that miR-9 may be of potential values as a novel therapeutic target for gastric cancer. The gene discussed is ETS1; the disease is gastric cancer.